The mammalian target of rapamycin (mTOR) pathway is essential for metabolic reprogramming in cancer, and FMRP’s interaction with this pathway points to its potential role in cancer cell metabolism [18] (Figure 1b). This evidence concerns the gene MTOR and cancer.